Bioton (LTS:0DTR) Asset Impairment Charge : zł0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Bioton Asset Impairment Charge?

Bioton's Asset Impairment Charge for the three months ended in Mar. 2024 was zł0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was zł0.0 Mil.

Bioton Asset Impairment Charge Historical Data

The historical data trend for Bioton's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Asset Impairment Charge Chart

Bioton Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

Bioton Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

Bioton Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.0 Mil.

Bioton Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Bioton's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioton (LTS:0DTR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (LTS:0DTR) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

BIO:Poland 7U5:Germany

Address

Ul. Staro?ci?ska 5, Warszawa, POL, 02-516

Website

http://www.bioton.pl

Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (LTS:0DTR) Headlines

No Headlines